MRSN
Mersana Therapeutics Inc

2,782
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 13,
Pre-Market

Estimated EPS

-$1.54

Estimated Rev

$14.2M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$1.54
--
--
N/A
Q2 '25
-$3.87
-$4.87
-26.00%
MISSED
Q1 '25
-$0.19
-$4.75
-2366.80%
MISSED
Q4 '24
-$0.16
-$0.11
31.30%
BEAT
Q3 '24
-$0.17
-$0.09
47.58%
BEAT

Latest MRSN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.